Long-term etanercept use for severe generalized psoriasis in an HIV-infected individual: a case study
Lee, E.S.; Heller, M.M.; Kamangar, F.; Park, K.K.; Koo, J.Y.M.
Journal of Drugs in Dermatology Jdd 11(3): 413-414
2012
ISSN/ISBN: 1545-9616 PMID: 22395596 Document Number: 13390
The treatment options for psoriasis in HIV-infected individuals are limited due to the immunosuppressive nature of the therapeutic modalities and the patient's immunocompromised state. Etanercept has been shown to be safe and effective in the non-HIV psoriasis population with nearly 20 years of experience. However, there is limited data on the safety of etanercept use in the HIV patient population. The authors report a case of an HIV-infected patient with psoriasis who has remained mostly clear on continuous, uninterrupted etanercept use for over six years.
Document emailed within 1 workday
